CN110433052A - The fat method of Hyperbaric Oxygen for Treatment high fat diet induction - Google Patents
The fat method of Hyperbaric Oxygen for Treatment high fat diet induction Download PDFInfo
- Publication number
- CN110433052A CN110433052A CN201910778190.2A CN201910778190A CN110433052A CN 110433052 A CN110433052 A CN 110433052A CN 201910778190 A CN201910778190 A CN 201910778190A CN 110433052 A CN110433052 A CN 110433052A
- Authority
- CN
- China
- Prior art keywords
- fat
- hyperbaric
- oxygen
- high fat
- 10min
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G10/00—Treatment rooms or enclosures for medical purposes
- A61G10/02—Treatment rooms or enclosures for medical purposes with artificial climate; with means to maintain a desired pressure, e.g. for germ-free rooms
- A61G10/023—Rooms for the treatment of patients at over- or under-pressure or at a variable pressure
- A61G10/026—Rooms for the treatment of patients at over- or under-pressure or at a variable pressure for hyperbaric oxygen therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G2210/00—Devices for specific treatment or diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses the fat methods of Hyperbaric Oxygen for Treatment high fat diet induction, and boost phase: average rate boosts to 1.8-2.0ATA in 5-10min;The pressure stabilizing stage: 50-70min, 1.8-2.2ATA;Buck stage: average rate drops to normal pressure in 5-10min;100% oxygen is supplied in cabin, hyperbaric oxygentherapy 1 time a day continues 3-4 weeks.The beneficial effects of the invention are as follows the intake of high fat diet after hyperbaric oxygentherapy in 3 weeks, is reduced, Energy intaking is reduced, reduces visceral fat weight and fat drips diameter, is lost weight.Increase brown fat, increases energy output.
Description
Technical field
The invention belongs to health care technology field, be related to it is a kind of using hyperbaric oxygen ation, adjuvant treatment high fat diet induction
Fat correlation, which is ingested, to be increased, the method for fat drips deposition and weight gain.
Background technique
Obesity is not only mankind's public health problem of global range, and 2018, fat association was defined as one kind
Disease.Fat early period and the fat occurrence and development that can dramatically increase more than 200 kinds of chronic diseases: compared with ideal body weight, moderate fertilizer
Fat person's diabetes prevalence is 10 times of normal type, and severe obesity illness rate may be up to 30 times.In addition, overweight or fat meeting
Increase metabolic syndrome, cardiovascular disease, respiratory disorder, fatty liver, dysgenesia, depression and kinds of tumor risk, very
The risk that children suffer from diabetes, cardiovascular disease, cancer and Stein-Leventhal syndrome can extremely be increased.With the improvement of living standards
Speeded with rhythm, people from low nutrition, high heat instant food and drink in the energy taken in increasingly increase, especially high-carbon hydrate
Object (cake, biscuit, pie, Pizza) and high sugar food (candy, cola drink).These foods account for adult gross energy intake respectively
36% and children's gross energy intake 41%, account for the 41% and 47% of the total fat intake of children.United States Department of Agriculture's report claims, In
In past 50 years, soft drink consumption amount increases nearly 500% per capita.It is opposite with Energy intaking is increased, cause fat increased another
One factor is due to depending on the daily energy consumption of the vehicles and laborsaving equipment limit unduly.However, not having at present
The specific medicament for having treatment fat is mainly that strict control of diet and increase move for this way to solve the problem.But
High glucose and high fat food can activate the award access of central nervous system, cause " food is addicted ", increase obese patient's feed constantly
Add and more have a preference for energy-dense foods, this pathophysiological mechanism becomes the serious obstruction of self diet control.On the other hand, long
The operating mode of seat depends on the daily energy consumption of the vehicles and laborsaving equipment limit, tired out and work pressure unduly
Power is a reason of limitation movement.Although strict control of diet and persistent movement can assist obesity controlling, compliance is poor,
Slow effect and it is also easy to produce long-term resentment, therefore is badly in need of a kind of new method that adjuvant treatment is fat.Hyperbaric oxygen ation (HBO) is
A technique for it is widely used in treating decompression sickness, air embolism and anthracemia, refers to that patient is being higher than 1 atmospheric pressure
In environment, the therapeutic scheme of 100% oxygen is breathed.It is chronic refractory in recent years used also as including impaired graft and flap
The adjuvant treatment of property osteomyelitis and diabetic foot ulcer.And hyperbaric oxygen ation is still blank in the application of fat auxiliary therapeutic area,
The present invention provides a kind of weight-reducing physical therapy for not needing to keep on a diet, adjuvant treatment obesity and pre- preventing obesity are related concurrent
Disease provides a kind of new application of hyperbaric oxygentherapy application.It there is no weight-reducing specific drug at present, strict control feed limits energy
It takes in and adheres to moving, the method compliance for increasing energy output is poor.It is badly in need of the new assistance control Energy intaking of one kind at present simultaneously
Increase power consumption methodology, does not need patient and lean on the stringent diet control of willpower, the object for not needing positive motion and taking drugs
Physical therapy method.
Summary of the invention
The purpose of the present invention is to provide the fat methods of Hyperbaric Oxygen for Treatment high fat diet induction, and of the invention is beneficial
After effect is hyperbaric oxygentherapy in 3 weeks, the intake of high fat diet is reduced, reduces Energy intaking, reduces visceral fat weight and rouge
Diameter is dripped, is lost weight.Increase brown fat, increases energy output.
The technical scheme adopted by the invention is that boost phase: average rate boosts to 1.8-2.0ATA in 5-10min;Pressure stabilizing rank
Section: 50-70min, 1.8-2.2ATA;Buck stage: average rate drops to normal pressure in 5-10min;100% oxygen is supplied in cabin, 1 time a day
Hyperbaric oxygentherapy continues 3-4 weeks.
Detailed description of the invention
Fig. 1 is the obese model of high fat diet induction;
Fig. 2 is experiment mouse figure;
Fig. 3 is influence of the different length hyperbaric oxygentherapy period to weight;
Fig. 4 is the influence after hyperbaric oxygentherapy to visceral fat weight;
Fig. 5 is the influence after hyperbaric oxygentherapy to epididymal adipose tissues fat drips size.
Specific embodiment
The present invention is described in detail With reference to embodiment.
The present invention program is as follows:
Boost phase: average rate boosts to 1.8-2.0ATA in 5-10min
The pressure stabilizing stage: 50-70min, 1.8-2.2ATA
Buck stage: average rate drops to normal pressure in 5-10min
100% oxygen is supplied in cabin,
Hyperbaric oxygentherapy 1 time a day continues 3-4 weeks.
Experimental verification:
1. high fat diet inducing obesity model foundation: C57BL/6J mouse is randomly divided into two groups, feeds normal diet respectively
(CD) and 45% high fat diet (HFD) obese model (Fig. 1) of high fat diet induction, is successfully established after 8 weeks, normal mouse is living
Jump, obesity mice roll up lazy move (Fig. 2).
2. influence of the different length hyperbaric oxygentherapy period to weight: after the obese model of building high fat diet induction, with
Machine is divided into normal diet group (CD);Normal diet+hyperbaric oxygen group (CD+HBO);High fat diet group (HFD);High fat diet+high pressure
Four groups of oxygen group (HFD+HBO) was adapted to by one week environment, started to carry out hyperbaric oxygentherapy, respectively in 1,2,3,4 end cycle
When survey weight (Fig. 3).
3. the influence to food-intake and Energy intaking: ingesting and measure the same day, fasting 12h after assessment hyperbaric oxygentherapy 3 weeks,
Food is given after hyperbaric oxygentherapy, measures 1,2,3 hours accumulation food rations, and match according to normal diet and the energy of high fat diet
Than calculating cumlative energy intake.
4. to the influence of visceral fat weight after hyperbaric oxygentherapy: after carrying out hyperbaric oxygentherapy in 4 weeks, taking kidney Zhou Baise rouge
Fat, measures weight, and assessment hyperbaric oxygen influences (Fig. 4) on it.
5. the influence (Fig. 5) after hyperbaric oxygentherapy to epididymal adipose tissues fat drips size.
6. the influence after hyperbaric oxygentherapy to heat production tissue brown fat: after hyperbaric oxygentherapy, brown fat color burn,
Brown fat caused by high fat diet " white esterification " reduces.
The above is only not to make limit in any form to the present invention to better embodiment of the invention
System, any simple modification that embodiment of above is made according to the technical essence of the invention, equivalent variations and modification,
Belong in the range of technical solution of the present invention.
Claims (1)
1. the fat method of Hyperbaric Oxygen for Treatment high fat diet induction, it is characterised in that:
Boost phase: average rate boosts to 1.8-2.0ATA in 5-10min;The pressure stabilizing stage: 50-70min, 1.8-2.2ATA;Decompression
Stage: average rate drops to normal pressure in 5-10min;100% oxygen is supplied in cabin, hyperbaric oxygentherapy 1 time a day continues 3-4 weeks.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910778190.2A CN110433052A (en) | 2019-08-22 | 2019-08-22 | The fat method of Hyperbaric Oxygen for Treatment high fat diet induction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910778190.2A CN110433052A (en) | 2019-08-22 | 2019-08-22 | The fat method of Hyperbaric Oxygen for Treatment high fat diet induction |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110433052A true CN110433052A (en) | 2019-11-12 |
Family
ID=68437092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910778190.2A Pending CN110433052A (en) | 2019-08-22 | 2019-08-22 | The fat method of Hyperbaric Oxygen for Treatment high fat diet induction |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110433052A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022011052A1 (en) * | 2020-07-08 | 2022-01-13 | Curiel Gabriel | Pressure differential-, ultrasound-, and magnetic-based methods for treating viral infections and other pathogenic diseases, sterilizing medical equipment, and enhancing fatty tissue reduction |
-
2019
- 2019-08-22 CN CN201910778190.2A patent/CN110433052A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022011052A1 (en) * | 2020-07-08 | 2022-01-13 | Curiel Gabriel | Pressure differential-, ultrasound-, and magnetic-based methods for treating viral infections and other pathogenic diseases, sterilizing medical equipment, and enhancing fatty tissue reduction |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3930808B2 (en) | Yeast-derived functional peptide having anti-stress function, anti-fatigue function, premenstrual syndrome and menstrual pain alleviating function and function as neurotrophic factor and method for producing the same | |
CN103238897A (en) | Composite plant solid drink suitable for diabetic patients | |
US11020415B2 (en) | Use of albiflorin in preparation of products for improving function of intestinal flora system | |
CN104147132A (en) | Soft gel capable of reducing blood sugar and adjusting insulin secretion and production method | |
RU2330653C2 (en) | Eicosapentaenoic acid (epa) for treatment of neuropsychic anorexia (na) | |
CN105030841A (en) | Application of Akkermansia muciniphila BAA-835 strain | |
CN108157953A (en) | A kind of full nutrition formula food and preparation method thereof | |
CN108094646A (en) | A kind of function candy relieved stress and preparation method thereof | |
CN1756544B (en) | Use of arachidonic acid for normalization of infradian rhythm | |
JP2004505042A (en) | Methods and compositions for prevention and / or treatment of diabetes and glucose degeneration | |
CN110433052A (en) | The fat method of Hyperbaric Oxygen for Treatment high fat diet induction | |
WO2005123058A1 (en) | Antiaging agent | |
JP2011241209A (en) | Bdnf production accelerator having ganglioside or derivative thereof as active ingredient, and medical product, food and drink and feed containing the bdnf production accelerator | |
CN101273775A (en) | Cordyceps mycelium capsules and producing process thereof | |
CN108782679A (en) | A kind of weight-reducing intervention is dry and preparation method thereof for refreshment | |
EP2989903A1 (en) | Food supplement for people with down syndrome, autism spectrum disorder and/or attention deficit disorder with or without hyperactivity | |
WO2004103383A1 (en) | A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein | |
CN110384240A (en) | Hypoglycemic vitamin and probiotics fermention object powder alimentation composition and its application | |
MX2013011144A (en) | Trpm5 inhibitors support body weight reduction without reducing food intake. | |
CN109999044B (en) | Composition containing withaferin A and application thereof | |
CN103330118A (en) | Antiobesity drug | |
Srivastava et al. | Nutraceutical Potential of pumpkin (Cucurbita sp.) powder, seed, extracts, and oil on diabetes; Mini Review | |
Kitamura | Diet therapy and food exchange lists for diabetic patients | |
CN101700119B (en) | Oral administration preparation for improving subhealth symptom of adult | |
CN117045652B (en) | Application of kynurenic acid in preparation of medicine for relieving and/or treating bulimia nervosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191112 |
|
RJ01 | Rejection of invention patent application after publication |